⚡ FAST WATCH — updated weekly

Not yet peer-reviewed, but worth following:

• May 30: Focused ultrasound (FUS) for Alzheimer's — small Chinese trial (n=7). Source →
• May 28: Personalized mRNA cancer vaccines — pancreatic + glioblastoma. Source →
• May 28: Universal kidney enzyme conversion. Source →
• May 27: TM5614 (PAI-1 inhibitor) — first human trial in healthy older adults. Source →
• May 24: PCC1 senolytic (grape seed/hawthorn) — human pilot data. Source →
• May 22: Anti‑IL‑11 therapy — mouse lifespan extension, human Phase II. Source →
• May 21: Tooth regrowth drug (TRG-035) — Phase I Japan. Source →
• May 21: Stem cell‑derived islet transplantation (type 1 diabetes). Source →
• May 20: Personalized DNA vaccine (GNOS-PV01) for glioblastoma. Source →
• May 19: Closed‑loop vascular cleaning (atherosclerosis) — hypothesis only. Source →

📬 Full citations added to monthly archive when peer-reviewed. Subscribe for the monthly digest.